Last synced on 14 November 2025 at 11:06 pm

ETEST Telavancin (TLA) (0.002-32 ug/mL)

Page Type
Cleared 510(K)
510(k) Number
K180936
510(k) Type
Traditional
Applicant
bioMerieux SA
Country
France
FDA Decision
Substantially Equivalent
Decision Date
7/3/2018
Days to Decision
84 days
Submission Type
Summary

ETEST Telavancin (TLA) (0.002-32 ug/mL)

Page Type
Cleared 510(K)
510(k) Number
K180936
510(k) Type
Traditional
Applicant
bioMerieux SA
Country
France
FDA Decision
Substantially Equivalent
Decision Date
7/3/2018
Days to Decision
84 days
Submission Type
Summary